Snakepit owner Peak succumbs to cancerCoeur d’Alene Press“Typically people with his diagnosis (multiple myeloma) live another two to five years … boy was he a fighter until the very end,” Haler said, adding that Peak had a stem cell transplant in…
Pharmaceutical Market Fails to Capture $188 Billion U.S. Revenue and $564 Billion Global Revenue Annually Due to …
Pharmaceutical Market Fails to Capture $188 Billion U.S. Revenue and $564 Billion Global Revenue Annually Due to Medication Non-Adherence
Isotechnika: FDA Oks To Begin Phase 3 Kidney Transplant Trials For Voclosporin – NASDAQ
Isotechnika: FDA Oks To Begin Phase 3 Kidney Transplant Trials For VoclosporinNASDAQThe primary endpoint of the trial will be defined as non-inferiority in biopsy proven acute rejection, or BPAR, episodes with patients receiving voclosporin for six mon…
Isotechnika: FDA Oks To Begin Phase 3 Kidney Transplant Trials For Voclosporin – RTT News
Isotechnika: FDA Oks To Begin Phase 3 Kidney Transplant Trials For VoclosporinRTT NewsThe primary endpoint of the trial will be defined as non-inferiority in biopsy proven acute rejection, or BPAR, episodes with patients receiving voclosporin for six m…
Isotechnika: FDA Oks To Begin Phase 3 Kidney Transplant Trials For Voclosporin
Isotechnika: FDA Oks To Begin Phase 3 Kidney Transplant Trials For Voclosporin
Dr. Eben Alexander's so-called after-life – Salon
Dr. Eben Alexander's so-called after-lifeSalonAccording to Cohen, the neocortical inactivity described by Dr. Alexander is “brain death, a 100 percent lethal condition.” By the time I met Dr. Alexander and mentioned his inactive neocortex, his …
Gujral on ventilator but stable, says son Naresh – Newstrack India
Gujral on ventilator but stable, says son NareshNewstrack IndiaGujral, 93, was admitted to the Medicity Medanta Hospital here with a lung infection on Nov 19. Another senior consultant at the hospital termed Gujral's condition "critical but st…
Isotechnika Cleared by FDA to Commence Phase 3 Voclosporin Trial – Equities.com
Isotechnika Cleared by FDA to Commence Phase 3 Voclosporin TrialEquities.comThe primary endpoint of the trial will be defined as non-inferiority in biopsy proven acute rejection, or BPAR, episodes with patients receiving voclosporin for six months as c…
Ceva Animal Health to host heart failure webinar – Zenopa
Ceva Animal Health to host heart failure webinarZenopaLasting 90 minutes, the seminar will offer best practice guidance on the management of heart failure, using real-life case studies to place the topic in an appropriate context. Dr Swift is the curre…
Cystatin C Less Predictive in Heart Failure Patients – Renal and Urology News
Cystatin C Less Predictive in Heart Failure PatientsRenal and Urology NewsTORONTO—Estimated glomerular filtration rate (eGFR) and serum creatinine values are more accurate than cystatin C levels in predicting acute hospitalization in patients with am…